Vitruvias Therapeutics Thyroid Tablet Recall: 'Superpotent' Pills Risk Elderly and Pregnant Patients
Vitruvias Therapeutics recalls 30 mg thyroid tablets nationwide over superpotency risks to elderly and pregnant patients. Learn more about the recall and safety steps.
International Business Times UK ·